AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Quadri Meningo Vaccine

Prescription Icon
Prescription Required

Marketer

Biomed Pharmaceuticals

Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135) (NA)

Overview Quadri Meningo Vaccine

Meningococcal vaccine, Quadri Meningo, protects against meningococcal disease, specifically invasive infections from serogroups A, C, Y, and W-135. Recommended for infants (two months and older), adolescents, and adults, this vaccine requires adherence to official guidelines. Administration must be by a qualified healthcare provider; self-injection is strictly prohibited. A complete vaccination course is crucial for optimal effectiveness. Common reactions at the injection site (pain, swelling, redness), along with nausea, headache, drowsiness, fretfulness, general discomfort, and muscle aches, may occur. Persistent or worsening symptoms warrant medical attention; your doctor can offer management strategies. Prior to vaccination, disclose any existing health conditions or medications to your physician. Pregnant or breastfeeding individuals should consult their doctor before receiving this vaccine.

Uses of Quadri Meningo Vaccine

Averting meningococcal infection

Major Benefits of Quadri Meningo Vaccine:

This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.

Common Side effects of Quadri Meningo Vaccine:

  • Injection site reaction
  • Sleepiness
  • Nausea
  • Headache
  • Irritation
  • Muscle pain

How to use Quadri Meningo Vaccine:

Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.

How Quadri Meningo Vaccine works:

The Quadri Meningo Vaccine prompts immune system development through the induction of a benign infection. This controlled infection, incapable of causing disease, triggers antibody production, safeguarding against subsequent meningococcal infections.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Quadri Meningo Vaccine is not definitively safe; physician consultation is recommended.

PregnancyPregnancySAFE IF PRESCRIBED

The safety profile of Quadri Meningo Vaccine during pregnancy is generally favorable. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; nonetheless, data from human trials remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The Quadri Meningo vaccine likely poses minimal risk during lactation. Available human data indicate negligible infant harm associated with maternal vaccination.

DrivingDrivingSAFE

The Quadri Meningococcal vaccine typically has no impact on driving capabilities.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Quadri Meningo Vaccine administration to individuals with renal impairment. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The safety profile of Quadri Meningo Vaccine in individuals with hepatic impairment appears favorable. Current evidence indicates that dose modification for this vaccine may be unnecessary in such patients. Physician consultation is recommended.

What if you forget to take Quadri Meningo Vaccine :

Omit a Quadri Meningo Vaccine dose? Seek your physician's advice.

Facts to Know About Quadri Meningo Vaccine

LabelValue
Type of Compound Immunizations
Potential for Dependence None.
Medication Classification IMMUNIZATIONS

FAQs on Quadri Meningo Vaccine

The meningococcal vaccine, Quadri Meningo, provides active immunization against invasive meningococcal disease stemming from serogroups A, C, Y, and W-135 of *Neisseria meningitidis*. This vaccine is licensed for individuals aged 2 months to 55 years.
Individuals with a history of allergic reactions to any component of Quadri Meningo Vaccine, or comparable medications, should not receive this vaccine. Allergic reactions can manifest as skin rash with itching, difficulty breathing, and facial or tongue swelling. Prior medication allergies should be disclosed to a physician.
A single booster shot of quadrivalent meningococcal vaccine can be given to people aged 15 to 55 who remain at high risk of meningococcal infection, provided at least four years have elapsed since their last dose. Seek medical advice if you have any concerns.
Administration of the Quadri Meningo Vaccine is exclusively performed by qualified medical personnel, such as physicians or trained healthcare providers; self-injection is strictly prohibited. The vaccine is typically injected into the deltoid muscle of the upper arm; however, thigh muscle injection may be used for pediatric patients. For optimal results, adhere precisely to your physician's prescribed vaccination protocol.
The Quadri Meningo Vaccine cannot cause meningococcal disease. Instead, it stimulates your immune system to generate protective antibodies, enabling your body to combat the infection should exposure occur.
Quadri Meningo Vaccine
944
MRP 1,150
17% off